StockNews.com cut shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a strong-buy rating to a buy rating in a report published on Monday morning.
Several other analysts have also recently issued reports on TCMD. B. Riley started coverage on Tactile Systems Technology in a research report on Thursday, September 26th. They set a “buy” rating and a $23.00 target price on the stock. BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th. Finally, Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th.
Get Our Latest Report on Tactile Systems Technology
Tactile Systems Technology Price Performance
Institutional Trading of Tactile Systems Technology
A number of institutional investors have recently bought and sold shares of the stock. Paradigm Capital Management Inc. NY lifted its stake in shares of Tactile Systems Technology by 90.1% during the second quarter. Paradigm Capital Management Inc. NY now owns 1,183,800 shares of the company’s stock worth $14,135,000 after buying an additional 561,073 shares during the period. Pinnacle Associates Ltd. grew its stake in Tactile Systems Technology by 324.9% during the 2nd quarter. Pinnacle Associates Ltd. now owns 317,024 shares of the company’s stock valued at $3,785,000 after purchasing an additional 242,413 shares during the last quarter. Essex Investment Management Co. LLC acquired a new position in shares of Tactile Systems Technology in the third quarter valued at about $1,803,000. Los Angeles Capital Management LLC purchased a new position in shares of Tactile Systems Technology in the second quarter worth about $1,187,000. Finally, Federated Hermes Inc. lifted its holdings in shares of Tactile Systems Technology by 26.5% during the second quarter. Federated Hermes Inc. now owns 433,660 shares of the company’s stock worth $5,178,000 after purchasing an additional 90,960 shares during the period. 83.43% of the stock is currently owned by institutional investors and hedge funds.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- CD Calculator: Certificate of Deposit Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.